Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with mild cognitive impairment (early memory and thinking problems) or Alzheimer's disease, rapid eye movement sleep behavior disorder (a condition where people act out their dreams), Parkinson's disease, epilepsy, or a malignant (cancerous) brain tumor, based on standard medical guidelines.
- People who are currently admitted to the hospital where this trial is taking place for inpatient treatment.
Who may not be able to join:
- People who have had radiation therapy or chemotherapy in the past three weeks, or who have taken medications specifically for Alzheimer's disease or Parkinson's disease in the past month.
- People who have ongoing seizures or a state of continuous seizure activity that cannot be controlled with medication, making it difficult to cooperate with the required examinations.
- People whose blood sugar levels are poorly controlled and have not responded to medication.
- People who have medical reasons that make a PET/MR scan (a type of brain imaging that combines two scanning methods) unsafe or unsuitable for them.
- People whose overall health and ability to carry out daily activities falls below a certain level, as measured by a standard medical scoring tool (confirm with trial site for the specific threshold).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jie Lu, Phd, Xuanwu Hospital of Capital Medical University
Phone: +86 13309824318
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
SUVr measurement in lesions by 18F-FDG PET images
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.